Ignite Creation Date:
2024-05-05 @ 4:39 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00287118
Status:
COMPLETED
Last Update Posted:
2018-04-03
First Post:
2006-02-02
Brief Title:
A Multicentre Open Label Phase IIIbIV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque Psoriasis
Sponsor:
Merck KGaA Darmstadt Germany
Organization:
Merck KGaA Darmstadt Germany
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-10-27
Start Date Type:
ACTUAL
Primary Completion Date:
2006-05-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-05-30
Completion Date Type:
ACTUAL
First Submit Date:
2006-02-02
First Submit QC Date:
February 2 2006
Study First Post Date:
2006-02-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-04-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-29
Last Update Post Date:
2018-04-03
Last Update Post Date Type:
ACTUAL